Journal article
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Abstract
BACKGROUND: Patients with active cancer have an increased risk of venous thromboembolism, which results in substantial morbidity, mortality, and health care expenditures. The Khorana score (range, 0 to 6, with higher scores indicating a higher risk of venous thromboembolism) has been validated to identify patients with cancer at elevated risk for this complication and may help select those who could benefit from thromboprophylaxis.
METHODS: We …
Authors
Carrier M; Abou-Nassar K; Mallick R; Tagalakis V; Shivakumar S; Schattner A; Kuruvilla P; Hill D; Spadafora S; Marquis K
Journal
New England Journal of Medicine, Vol. 380, No. 8, pp. 711–719
Publisher
Massachusetts Medical Society
Publication Date
February 21, 2019
DOI
10.1056/nejmoa1814468
ISSN
0028-4793